These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 17884792)
21. [Value of cervical liquid-based cytology and high-risk human papilloma virus for patients of high-grade squamous intraepithelial lesion excised with positive margins by loop electrosurgical excision procedure]. Chen Y; Wu D; Li Z; Xu Y; Yu J; Ji R Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1331-4. PubMed ID: 26081665 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of Brn-3a immunocytochemistry of liquid-based ThinPrep cytology test in early diagnosis of cervical process]. Guo XD; Niu K; Zhao JM; Xiong L; Zhang X; Zhao YL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):801-2. PubMed ID: 22031962 [TBL] [Abstract][Full Text] [Related]
23. [HPV test in the prevention of cervix cancer]. Sørbye SW; Fismen S; Gutteberg TJ; Mortensen E Tidsskr Nor Laegeforen; 2012 Feb; 132(4):396-7. PubMed ID: 22353829 [No Abstract] [Full Text] [Related]
24. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening. Liang H; Fu M; Zhou J; Song L Oncol Lett; 2016 Aug; 12(2):887-892. PubMed ID: 27446364 [TBL] [Abstract][Full Text] [Related]
25. Cervical cancer biopsy reporting: a review. Reyes MC; Cooper K Indian J Pathol Microbiol; 2014; 57(3):364-8. PubMed ID: 25118724 [TBL] [Abstract][Full Text] [Related]
26. American Cancer Society signals transition in cervical cancer screening from cytology to HPV tests. Davey DD Cancer Cytopathol; 2021 Apr; 129(4):259-261. PubMed ID: 33826791 [No Abstract] [Full Text] [Related]
27. Has cytology become obsolete as a primary test in screening for cervical cancer? Rebolj M; Lynge E J Med Screen; 2010; 17(1):1-2. PubMed ID: 20356936 [No Abstract] [Full Text] [Related]
28. Has cytology become obsolete as a primary test in screening for cervical cancer? Sasieni P J Med Screen; 2010; 17(1):2-3. PubMed ID: 20356937 [No Abstract] [Full Text] [Related]
29. Clinical applicability of microarray technology in the diagnosis, prognostic stratification, treatment and clinical surveillance of cervical adenocarcinoma. Chepovetsky J; Kalir T; Weiderpass E Curr Pharm Des; 2013; 19(8):1425-9. PubMed ID: 23016775 [TBL] [Abstract][Full Text] [Related]
30. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934 [TBL] [Abstract][Full Text] [Related]
31. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance]. Zhao J; Zhou JN; Yang YJ; Liao QP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350 [TBL] [Abstract][Full Text] [Related]
32. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion]. Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634 [TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532 [TBL] [Abstract][Full Text] [Related]
34. [Application of liquid-based cytology and high-risk human papillomavirus DNA detection in cervical lesion screening]. Wu D; Ding L; Wu JH; Li ZN Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1421-3. PubMed ID: 17884792 [TBL] [Abstract][Full Text] [Related]